For research use. These pages describe what a knowledge graph asserts; they are not clinical advice and must not guide the treatment of a patient.

DrugApprovals KP (opens the knowledge source's documentation in a new tab) version 1.23.4 latest

This relationship states that Tygacil (opens identifiers.org in a new tab) was applied off label to treat mycobacterial infectious disease (opens monarchinitiative.org in a new tab).

897ef74c-7451-33a0-b314-accff185d73c Download KGX

Stored versions

Changes

1 field differ between infores:drugapprovals-kp-1.23.3 and infores:drugapprovals-kp-1.23.4 (+ added / - removed):

Changed lists

  • Knowledge sources
    • added {"resource_id":"infores:drugapprovals-kp","resource_role":"primary_knowledge_source","source_record_urls":["https://linkouts.skyelanegoetz.com/edges/897ef74c-7451-33a0-b314-accff185d73c"],"upstream_resource_ids":["infores:dailymed","infores:faers","infores:canada-vigilance"]}
    • removed {"resource_id":"infores:drugapprovals-kp","resource_role":"primary_knowledge_source","source_record_urls":["https://db.systemsbiology.net/gestalt/cgi-pub/KGinfo.pl?id=897ef74c-7451-33a0-b314-accff185d73c"],"upstream_resource_ids":["infores:dailymed","infores:faers","infores:canada-vigilance"]}

About this knowledge graph

The DrugApprovals KP curates assertions of FDA- and EMA-approved treatment relationships, usages observed in FAERS and Health Canada's Canada Vigilance database and applied to treat, and contraindications text-mined from DailyMed labeling; these assertions are derived from DailyMed, Drugs@FDA, FAERS, Canada Vigilance, and the EMA medicines registry.

Something wrong with this relationship? Open an issue. (opens GitHub in a new tab)